BlackRock Investment Management, LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 108 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$1,349,000
-18.5%
950,129
+0.5%
0.00%0.0%
Q3 2016$1,655,000
+2.2%
945,725
-0.2%
0.00%0.0%
Q2 2016$1,620,000
-1.7%
947,551
+13.3%
0.00%0.0%
Q1 2016$1,648,000
+6.6%
836,603
+2.8%
0.00%0.0%
Q4 2015$1,546,000
-0.8%
813,789
-0.3%
0.00%0.0%
Q3 2015$1,558,000
-59.1%
815,877
-0.6%
0.00%
-60.0%
Q2 2015$3,807,000
+30.4%
820,461
+22.8%
0.01%
+25.0%
Q1 2015$2,920,000
+40.2%
668,239
+11.4%
0.00%
+33.3%
Q4 2014$2,082,000
-17.8%
599,904
-0.8%
0.00%
-25.0%
Q3 2014$2,533,000
-28.1%
604,639
+0.6%
0.00%
-20.0%
Q2 2014$3,523,000
-9.6%
601,165
-2.9%
0.01%
-16.7%
Q1 2014$3,899,000
+8.3%
618,938
+0.5%
0.01%
+20.0%
Q4 2013$3,601,000
+8.3%
615,624
-2.5%
0.01%0.0%
Q3 2013$3,326,000
-27.8%
631,159
+5.5%
0.01%
-37.5%
Q2 2013$4,608,000598,3850.01%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 867,700$5,085,0001.68%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 4,369,066$25,603,0001.03%
Lyons Wealth Management, LLC. 56,775$334,0000.30%
Callan Capital, LLC 66,118$387,0000.10%
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC 383,050$2,245,0000.06%
FCG ADVISORS, LLC 10,600$62,0000.05%
OppenheimerFunds, Inc. 7,000,000$41,020,0000.04%
NEXT Financial Group, Inc 19,704$86,0000.04%
WELLINGTON MANAGEMENT GROUP LLP 27,893,387$163,455,0000.04%
MURPHY CAPITAL MANAGEMENT INC 45,000$263,0000.04%
View complete list of ARENA PHARMACEUTICALS INC shareholders